Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Apr 22;310(6986):1060–1062. doi: 10.1136/bmj.310.6986.1060

Should patients positive for HIV infection receive pneumococcal vaccine?

A Jain 1, S Jain 1, V Gant 1
PMCID: PMC2549438  PMID: 7503844

Abstract

Pneumococcal vaccination effectively reduces the incidence of invasive pneumococcal disease in normal subjects. Such invasive pneumococcal disease is 100 times more common in patients with HIV infection than in healthy people, so it seems logical to target this group of patients for vaccination. Few clinics routinely vaccinate patients positive for HIV, despite Department of Health guidelines. This is because of uncertainty about the vaccine's efficacy in HIV disease. There are many reasons to suspect that the vaccine will fail to protect these patients, including the fact that antibodies alone may not be sufficient protection against all serogroups of Pneumococcus and the vaccine works in healthy people but not immunocompromised subjects. Vaccination of HIV positive patients may not be indicated, at least for the time being. The cost of vaccinating such patients in the absence of data showing efficacy may well be less than the cost of a necessarily large and lengthy trial. But the truth must be sought to end current indecision.

Full text

PDF
1060

Images in this article

1060p1060-a
on p.1060
1061p1061-a
on p.1061

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammann A. J., Schiffman G., Abrams D., Volberding P., Ziegler J., Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA. 1984 Mar 16;251(11):1447–1449. [PubMed] [Google Scholar]
  2. Bender B. S., Frank M. M., Lawley T. J., Smith W. J., Brickman C. M., Quinn T. C. Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. J Infect Dis. 1985 Aug;152(2):409–412. doi: 10.1093/infdis/152.2.409. [DOI] [PubMed] [Google Scholar]
  3. Chirurgi V. A., Edelstein H., McCabe R. Pneumococcal bacteremia as a marker for human immunodeficiency virus infection in patients without AIDS. South Med J. 1990 Aug;83(8):895–899. doi: 10.1097/00007611-199008000-00012. [DOI] [PubMed] [Google Scholar]
  4. Douglas R. M., Hansman D., Miles H. B., Paton J. C. Pneumococcal carriage and type-specific antibody. Failure of a 14-valent vaccine to reduce carriage in healthy children. Am J Dis Child. 1986 Nov;140(11):1183–1185. doi: 10.1001/archpedi.1986.02140250109044. [DOI] [PubMed] [Google Scholar]
  5. Ellis M., Gupta S., Galant S., Hakim S., VandeVen C., Toy C., Cairo M. S. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis. 1988 Dec;158(6):1268–1276. doi: 10.1093/infdis/158.6.1268. [DOI] [PubMed] [Google Scholar]
  6. Gillespie S. H. Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. J Med Microbiol. 1989 Apr;28(4):237–248. doi: 10.1099/00222615-28-4-237. [DOI] [PubMed] [Google Scholar]
  7. Glaser J. B., Volpe S., Aguirre A., Simpkins H., Schiffman G. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis. 1991 Oct;164(4):761–764. doi: 10.1093/infdis/164.4.761. [DOI] [PubMed] [Google Scholar]
  8. Gray B. M., Dillon H. C., Jr Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis. 1986 Mar-Apr;5(2):201–207. doi: 10.1097/00006454-198603000-00009. [DOI] [PubMed] [Google Scholar]
  9. Hamilos D. L., Young R. M., Peter J. B., Agopian M. S., Iklé D. N., Barka N. Hypogammaglobulinemia in asthmatic patients. Ann Allergy. 1992 Jun;68(6):472–481. [PubMed] [Google Scholar]
  10. Hansman D., Morris S. Pneumococcal carriage amongst children in Adelaide, South Australia. Epidemiol Infect. 1988 Oct;101(2):411–417. doi: 10.1017/s0950268800054364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Janoff E. N., Breiman R. F., Daley C. L., Hopewell P. C. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med. 1992 Aug 15;117(4):314–324. doi: 10.7326/0003-4819-117-4-314. [DOI] [PubMed] [Google Scholar]
  12. Janoff E. N., Douglas J. M., Jr, Gabriel M., Blaser M. J., Davidson A. J., Cohn D. L., Judson F. N. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis. 1988 Nov;158(5):983–990. doi: 10.1093/infdis/158.5.983. [DOI] [PubMed] [Google Scholar]
  13. Klein R. S., Selwyn P. A., Maude D., Pollard C., Freeman K., Schiffman G. Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. J Infect Dis. 1989 Nov;160(5):826–831. doi: 10.1093/infdis/160.5.826. [DOI] [PubMed] [Google Scholar]
  14. Kroon F. P., van Dissel J. T., de Jong J. C., van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS. 1994 Apr;8(4):469–476. doi: 10.1097/00002030-199404000-00008. [DOI] [PubMed] [Google Scholar]
  15. Lacey R. W., Lewis E. Letter: Is co-trimoxazole bactericidal in sputum? Br Med J. 1973 Oct 20;4(5885):165–165. doi: 10.1136/bmj.4.5885.165-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Musher D. M., Chapman A. J., Goree A., Jonsson S., Briles D., Baughn R. E. Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis. 1986 Aug;154(2):245–256. doi: 10.1093/infdis/154.2.245. [DOI] [PubMed] [Google Scholar]
  17. Parkin J. M., Helbert M., Hughes C. L., Pinching A. J. Immunoglobulin G subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS. AIDS. 1989 Jan;3(1):37–39. [PubMed] [Google Scholar]
  18. Pinching A. J. Antibody responses in HIV infection. Clin Exp Immunol. 1991 May;84(2):181–184. [PMC free article] [PubMed] [Google Scholar]
  19. Pos O., Stevenhagen A., Meenhorst P. L., Kroon F. P., Van Furth R. Impaired phagocytosis of Staphylococcus aureus by granulocytes and monocytes of AIDS patients. Clin Exp Immunol. 1992 Apr;88(1):23–28. doi: 10.1111/j.1365-2249.1992.tb03033.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Redd S. C., Rutherford G. W., 3rd, Sande M. A., Lifson A. R., Hadley W. K., Facklam R. R., Spika J. S. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis. 1990 Nov;162(5):1012–1017. doi: 10.1093/infdis/162.5.1012. [DOI] [PubMed] [Google Scholar]
  21. Rodriguez-Barradas M. C., Musher D. M., Lahart C., Lacke C., Groover J., Watson D., Baughn R., Cate T., Crofoot G. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992 Mar;165(3):553–556. doi: 10.1093/infdis/165.3.553. [DOI] [PubMed] [Google Scholar]
  22. Rose D. N., Schechter C. B., Sacks H. S. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med. 1993 Feb;94(2):160–168. doi: 10.1016/0002-9343(93)90178-r. [DOI] [PubMed] [Google Scholar]
  23. Saunders D. GP facilitators and HIV infection. BMJ. 1994 Jan 1;308(6920):2–3. doi: 10.1136/bmj.308.6920.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schatz D. A., Barrett D. J. Evolution of the subclass of IgG antibody to type 3 pneumococcal polysaccharide during childhood. Clin Exp Immunol. 1987 Nov;70(2):449–455. [PMC free article] [PubMed] [Google Scholar]
  25. Shapiro E. D., Berg A. T., Austrian R., Schroeder D., Parcells V., Margolis A., Adair R. K., Clemens J. D. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991 Nov 21;325(21):1453–1460. doi: 10.1056/NEJM199111213252101. [DOI] [PubMed] [Google Scholar]
  26. Shapiro E. D., Clemens J. D. A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. Ann Intern Med. 1984 Sep;101(3):325–330. doi: 10.7326/0003-4819-101-3-325. [DOI] [PubMed] [Google Scholar]
  27. Simberkoff M. S., Cross A. P., Al-Ibrahim M., Baltch A. L., Geiseler P. J., Nadler J., Richmond A. S., Smith R. P., Schiffman G., Shepard D. S. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Nov 20;315(21):1318–1327. doi: 10.1056/NEJM198611203152104. [DOI] [PubMed] [Google Scholar]
  28. Simberkoff M. S., El Sadr W., Schiffman G., Rahal J. J., Jr Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis. 1984 Dec;130(6):1174–1176. doi: 10.1164/arrd.1984.130.6.1174. [DOI] [PubMed] [Google Scholar]
  29. Sims R. V., Steinmann W. C., McConville J. H., King L. R., Zwick W. C., Schwartz J. S. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 1988 May;108(5):653–657. doi: 10.7326/0003-4819-108-5-653. [DOI] [PubMed] [Google Scholar]
  30. Unsworth D. J., Rowen D., Carne C., Sonnex C., Baglin T., Brown D. L. Defective IgG2 response to Pneumovax in HIV seropositive patients. Genitourin Med. 1993 Oct;69(5):373–376. doi: 10.1136/sti.69.5.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Webster A. D., Latif A. A., Brenner M. K., Bird D. Evaluation of test immunisation in the assessment of antibody deficiency syndromes. Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1864–1866. doi: 10.1136/bmj.288.6434.1864. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES